BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that management will be presenting at the UBS Genomics 2.0 and MedTech Innovations...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the company will begin remediation for the February 4, 2020 BD Alaris™ System1 recall...
With continuous pressure on our natural resources and the predicted impacts of climate change, it is important that we create a supply chain and operations model that is adaptable to disruption...
BD’s Jessica Gemmell has been selected by DiversityPlus Magazine as one of the 2021 Top 15 Women in Power Impacting Diversity in recognition of her efforts to drive measurable results in the...
Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health. This is how we make a difference in human health across generations. This is our work and this is our passion.
The BD Innovation and Engagement Center in Eysins Switzerland offers visiting healthcare professionals a collaborative and immersive environment to grasp the full scope of BD solutions to healthcare challenges across the care continuum.
